BIOLIPOX
Biolipox is a research-intense pharmaceutical company that develops treatments for inflammatory diseases. This includes widespread diseases such as asthma, COPD, rhinitis, and inflammatory and rheumatic pain. The company offers its users with current arachidonic acid research. Arachidonic acid is an endogenous substance that plays a central role in the development of inflammatory diseases. It is an established research area that empowers several drugs such as Aspirin, Naproxen, and Singulair. Biolipox is a Sweden-based company that was founded in 2000 and the company was acquired by Orexo on November 23, 2007.
BIOLIPOX
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2000-01-01
Address:
Solna, Stockholms Lan, Sweden
Country:
Sweden
Status:
Active
Total Funding:
62 M USD
Similar Organizations
AM Pharma
AM-Pharma is a biopharmaceutical company focused on the development of therapeutics to treat inflammatory and infectious diseases.
BIOVIIIx
BIOVIIIx is a biotechnology and pharmaceutical company that develops medicine in the field of rare diseases.
Corticrine
Corticrine operates as a pharmaceutical company that develops new therapies for Alzheimer’s dementia.
Ducentis BioTherapeutics
Ducentis is a pre-clinical stage company that aims to develop novel therapies for inflammation and autoimmune disease.
IntelliHep
IntelliHep is a spin-out company developing novel drugs for Alzheimers disease and cancer.
Ixaltis
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.
Spinal Cord Therapeutics GmbH
Spinal Cord Therapeutics GmbH develops treatments for spinal cord injury.
Systasy Bioscience
Systasy Bioscience is a biomedical research has radically changed the view to new treatment strategies.
Triptcor Pharmaceuticals
Triptcor Pharmaceuticals, a start-up based on inflammatory disease.
VitaLeech Bioscience
VitaLeech Bioscience develops a recombinant enzyme for the treatÂment of periodontitis, a form of inflammation of the gum.
Investors List
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series C - Biolipox
Sofinnova Partners
Sofinnova Partners investment in Series C - Biolipox
Auriga Partners
Auriga Partners investment in Series C - Biolipox
HealthCap
HealthCap investment in Series C - Biolipox
Apax Partners
Apax Partners investment in Series C - Biolipox
Angel Investment Network
Angel Investment Network investment in Series C - Biolipox
Auriga Partners
Auriga Partners investment in Series B - Biolipox
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series B - Biolipox
Sofinnova Partners
Sofinnova Partners investment in Series B - Biolipox
Apax Partners
Apax Partners investment in Series B - Biolipox